Biofrontera Inc reports results for the quarter ended September 30 - Earnings Summary

Biofrontera

14/11/2024 03:52

* Biofrontera Inc  BFRI.OQ  reported a quarterly adjusted
loss
of 98 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-4.64.  The mean expectation of two analysts
for the quarter was for a loss of 83 cents per share. Wall
Street expected results to range from -94 cents to -73 cents per
share.
    * Revenue rose 1.3% to $9.01 million from a year ago;
analysts
expected $10.01 million. 
    * Biofrontera Inc's reported EPS for the quarter was a loss
of 98
cents​.
    * The company reported a quarterly loss of $5.67 million.
    * Biofrontera Inc shares had fallen by 29.2% this
quarter and
lost 66.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 72.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Biofrontera Inc
is 11.50 
This summary was machine generated from LSEG data November 14 at
03:52 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.83          -0.98          Missed
 Jun. 30 2024      -0.77          -0.05          Beat
 Mar. 31 2024      -1.17          -2.88          Missed
 Dec. 31 2023      -1.19          -1.80          Missed